logo

For the Inventor, By the Inventor

Kawasaki, Japan

Toshihiro Hatanaka

This inventor holds 18 USPTO granted patents, primarily in Diabetes Therapeutics. Top assignee: Ajinomoto Co., Ltd.. Active years: 1997-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Toshihiro Hatanaka. Retrieved from https://idiyas.com/inventor/toshihiro-hatanaka

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 18

% Patents Active = 5.6

Average Co-Inventor Count = 8.7

ph-index = 6

Forward Citations = 160(Granted Patents)


Company Filing History:

goldMedal18 out of 1,953 
 
Ajinomoto Co., Ltd.
 patents

Years Active: 1997-2015

Loading Chart...
Areas of Expertise:
CaSR Agonists
Fused Polycyclic Compounds
Diabetes Mellitus
Acylamide Compounds
Pyrazole Derivatives
Lactam Compounds
Benzene Compounds
N-Substituted Pyrazole-O-Glycoside
Heterocyclic Compounds
Stilbene Compounds
Therapeutic Agents
Pharmaceutical Compositions
18 patents (USPTO):Explore Patents
1. 9174932 - CaSR agonists (2015-11-03),
2. 8796485 - CaSR agonists (2014-08-05),
3. 8299064 - Fused polycyclic compounds having a heterocyclic ring(s) and pharmaceutical use thereof (2012-10-30),
4. 7956041 - Prophylactic and therapeutic agent of diabetes mellitus (2011-06-07),
5. 7928101 - Fused polycyclic compounds having a heterocyclic ring(s) and pharmaceutical use thereof (2011-04-19),
6. 7732637 - Acylamide compounds having secretagogue or inducer activity of adiponectin (2010-06-08),
7. 7645787 - Pyrazole derivatives and diabetic medicine containing them (2010-01-12),
8. 7632830 - Lactam compounds and pharmaceutical use thereof (2009-12-15),
9. 7402696 - Benzene compounds (2008-07-22),
10. 7326701 - Lactam compounds and pharmaceutical use thereof (2008-02-05),
11. 7256209 - Pyrazole derivatives and diabetic medicine containing them (2007-08-14),
12. 7247616 - Pyrazole derivatives and diabetic medicine containing them (2007-07-24),
13. 7153850 - Lactam compounds and pharmaceutical use thereof (2006-12-26),
14. 7015201 - Pyrazole derivatives and diabetic medicine containing them (2006-03-21),
15. 6908905 - N-substituted pyrazole-O-glycoside derivatives and therapeutic agent for diabetes containing the same (2005-06-21),

Title: The Innovations of Toshihiro Hatanaka

Introduction

Toshihiro Hatanaka is a prominent inventor based in Kawasaki, Japan. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that exhibit CaSR agonistic activity. With a total of 18 patents to his name, Hatanaka's work has the potential to impact various therapeutic areas.

Latest Patents

Hatanaka's latest patents focus on CaSR agonists. By searching for various compounds that possess CaSR agonistic activity, he has developed agents that can be used in pharmaceutical compositions. These agents serve as preventive or therapeutic solutions for diarrhea and kokumi-imparting agents. More specifically, his inventions include glutamic acid derivatives that exhibit CaSR agonistic activity or their pharmaceutically acceptable salts.

Career Highlights

Hatanaka is associated with Ajinomoto Co., Ltd., a leading company in the food and pharmaceutical industries. His work at Ajinomoto has allowed him to explore innovative solutions that address health-related issues through the development of new compounds.

Collaborations

Hatanaka has collaborated with notable colleagues, including Nobuo Kondo and Hiroyuki Matsueda. These collaborations have further enriched his research and development efforts, leading to advancements in the field.

Conclusion

Toshihiro Hatanaka's contributions to the field of pharmaceutical sciences through his innovative patents highlight his role as a key inventor. His work continues to pave the way for new therapeutic agents that can improve health outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…